Genapsys Stock
DNA Sequencing Technology
About Genapsys Stock
GenapSys is actively looking to partner with local health agencies and researchers to arm researchers with access to the insight afforded by sequencing. With its sequencing technology, the company aims to help support the control and limit the spread of current and future outbreaks. The device can run off of a standard power source and is small enough to fit in the back of a truck or be deployed at hospitals, airports, and public transportation hubs for quick results on virus samples.
Investors
Funding History
| September 2012 | $5.5M |
|---|---|
| March 2013 | $8.5M |
| November 2013 | $37.5M |
| January 2018 | $32.5M |
| November 2019 | $90.0M |
| February 2020 | $75.0M |
Management
Founder & Chief Executive Officer
Hesaam Esfandyarpour
Press
FierceBiotech - Feb, 6 2020
GEN - Feb, 6 2020
GenomeWeb - Nov, 20 2019
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Genapsys or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
